Pittsburgh cancer doctors explain why less treatment can sometimes mean better outcomes
Key Points:
- Cancer treatment has shifted from a "more is better" approach to more precise, individualized care that aims to minimize side effects without compromising survival chances.
- Advances in genetics and cancer subtyping have enabled oncologists to tailor therapies, such as shorter chemotherapy durations for some Stage 3 colon cancer patients and avoiding treatment in certain early breast cancer cases.
- De-escalation strategies include choosing less invasive surgeries, using genomic profiles to guide therapy, and employing targeted radiation or immune therapies in reduced doses or durations.
- Multidisciplinary teamwork is now standard in cancer care, integrating surgery, medicine, and radiation to optimize treatment plans for each patient.
- This approach contrasts with the previous decades-long trend of escalating treatment intensity, reflecting a more nuanced understanding of cancer as a systemic disease and the potential for smarter, less aggressive interventions.